Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Bevacizumab + Triamcinolone in Refractory DME
NCT00370422Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2005
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab, triamcinolone in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
bevacizumabtriamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00370422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370422.